Calreticulin (CALR) (Middle Region) Peptide
Aperçu rapide pour Calreticulin (CALR) (Middle Region) Peptide (ABIN8096070)
Antigène
Origine
Source
Application
-
-
Protein Region
- Middle Region
-
Fonction
- CALR Peptide - middle region
-
Séquence
- ASKPEDWDER AKIDDPTDSK PEDWDKPEHI PDPDAKKPED WDEEMDGEWE
-
-
Calreticulin (CALR) peptide (Ovalbumin)
CALR Reactivité: Humain Hôte: Synthetic WB, Imm, SDS
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-CALR Antibody(ARP58880_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Calreticulin (CALR)
-
Sujet
-
Background Information: Calreticulin is a multifunctional protein that acts as a major Ca(2+)-binding (storage) protein in the lumen of the endoplasmic reticulum. It is also found in the nucleus, suggesting that it may have a role in transcription regulation. Calreticulin binds to the synthetic peptide KLGFFKR, which is almost identical to an amino acid sequence in the DNA-binding domain of the superfamily of nuclear receptors. Calreticulin binds to antibodies in certain sera of systemic lupus and Sjogren patients which contain anti-Ro/SSA antibodies, it is highly conserved among species, and it is located in the endoplasmic and sarcoplasmic reticulum where it may bind calcium.
Alternative Symbols: CRT, FLJ26680, RO, SSA, cC1qR
-
Poids moléculaire
- 46kDa
-
ID gène
- 811
-
NCBI Accession
- NP_004334
-
UniProt
- P27797
Antigène
-
